Lupus clue: can a heart drug reveal hidden disease markers?
NCT ID NCT02320357
First seen May 14, 2026 · Last updated Jun 14, 2026 · Updated 6 times
Summary
This small pilot study looked at whether clopidogrel, a drug that stops blood clots, could lower a substance called sCD40L in people with lupus. Lupus is an autoimmune disease where the body attacks itself. The study involved 18 adults with lupus and measured sCD40L levels in their blood. The goal was to learn more about the disease, not to treat it directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Service de Médecine Interne
Limoges, 87000, France
-
Service de Médecine Interne et Immunopathologie
Toulouse, 31 000, France
-
Service de Médecine Interne et maladies Infectieuses - Hôpital Saint-André
Bordeaux, Bordeaux, 33075, France
Conditions
Explore the condition pages connected to this study.